Condition
Head and Neck (HNSCC) clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Head and Neck (HNSCC) clinical trials that are recruiting, at sites in 5 countries (most in Jordan (1), South Korea (1), United States (1)). 1 was first registered in the last 30 days. By phase: Phase 1/2 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1New in 30 days
- 5Countries
Newest Head and Neck (HNSCC) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Phenotype-based Pain Guidance for Head and Neck Cancer-Related Pain (pilot) | Phase 2 | Lahore, Punjab Province | Recruiting | Nov 5, 2026 |
| Hyperfractionated radiotherapy vs high-dose cisplatin-based chemoradiation for head and neck cancer | — | Amman | Recruiting | Sep 3, 2026 |
| Matching tumor and blood gene tests for HPV-negative head and neck cancer | — | Milan and 1 other locations | Recruiting | Apr 6, 2026 |
| GI-108 monotherapy for people with advanced or metastatic solid tumors | Phase 1/2 | Seoul and 2 other locations | Recruiting | Sep 15, 2025 |
| CP-383 for advanced or metastatic solid tumors | Phase 1/2 | Denver, Colorado and 12 other locations | Recruiting | Jun 22, 2025 |
All recruiting trials (5)
-
Phenotype-based Pain Guidance for Head and Neck Cancer-Related Pain (pilot)
This pilot test sees if tailoring pain treatment to a patient’s pain type can reduce head and neck cancer pain in adults who haven’t started cancer treatment yet.
-
Hyperfractionated radiotherapy vs high-dose cisplatin-based chemoradiation for head and neck cancer
This trial tests whether giving hyperfractionated radiation therapy is as effective as high-dose cisplatin with radiation for people with head and neck squamous cell carcinoma.
-
Matching tumor and blood gene tests for HPV-negative head and neck cancer
This project will try to see if a simple blood test can show the same tumor gene patterns as tissue samples in people with HPV-negative head and neck cancer.
-
GI-108 monotherapy for people with advanced or metastatic solid tumors
We are testing GI-108 by itself to see if it is safe and can shrink tumors in people with advanced or metastatic solid tumors, including lung, head and neck, and pancreatic cancers.
-
CP-383 for advanced or metastatic solid tumors
This trial tests whether the oral drug CP-383 can slow or stop growth in adults with advanced or metastatic solid tumors who have exhausted standard treatments.
Related topics
Quick answers
How many Head and Neck (HNSCC) clinical trials are recruiting right now?
5, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in Jordan (1 trial), South Korea (1 trial), United States (1 trial), Italy (1 trial), Pakistan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.